Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Innovation showcase displays growing influence
2024-04-30 17:41
BioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special Report
2024-04-30 15:00
Innovent Announces the Appointment of Dr. Samuel Zhang as Global Chief Business Officer (CBO)
2024-04-30 12:30
WuXi Biologics Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment
2024-04-30 10:55
CARsgen Submitted Responses to FDA Observations
2024-04-29 20:50
Henlius Trastuzumab Receives FDA Approval in the United States
2024-04-29 20:18
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
2024-04-29 20:00
Technoderma Medicines Advances TDM-180935 Atopic Dermatitis Clinical Program with Phase 2 Trial
2024-04-29 20:00
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
2024-04-29 20:00
WuXi AppTec Achieved First Quarter 2024 Target Despite External Challenges, Maintaining Stable Operations
2024-04-29 19:00
Angel Yeast Publishes 2023 Corporate Social Responsibility Report
2024-04-29 19:00
DP Technology DevDay 2024 Showcases Large Science Models and Announces Open Science Initiative
2024-04-29 15:31
Prota Therapeutics' CEO Mimi Tang honoured at BioMelbourne Network's Women in Leadership Awards 2024
2024-04-29 10:40
Ractigen Therapeutics Announces FDA Approval for RAG-01, a First-in-Class saRNA Therapy for BCG-Unresponsive NMIBC
2024-04-26 21:00
Novel T-cell engager, CDH17 X CD3 cabotamig (ARB202) continues to explore dosing in patients with advanced gastrointestinal cancers
2024-04-26 21:00
Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa
2024-04-26 12:39
Hyosung TNC presents a new paradigm through sustainable bio BDO production.
2024-04-26 08:00
Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints
2024-04-26 01:25
2024 ASCO | Mabwell to Present Clinical Data of 9MW2821 in Multiple Advanced Solid Tumor
2024-04-25 22:00
Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil
2024-04-25 21:41
1
38
39
40
41
42
451